Literature DB >> 26297828

Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes.

Andreas van Maarschalkerweerd1, Valeria Vetri2, Bente Vestergaard3.   

Abstract

Oligomeric species formed during α-synuclein fibrillation are suggested to be membrane-disrupting agents, and have been associated with cytotoxicity in Parkinson's disease. The majority of studies, however, have revealed that the effect of α-synuclein oligomers is only noticeable on systems composed of anionic lipids, while the more physiologically relevant zwitterionic lipids remain intact. We present experimental evidence for significant morphological changes in zwitterionic membranes containing cholesterol, induced by α-synuclein oligomers. Depending on the lipid composition, model membranes are either unperturbed, disrupt, or undergo dramatic morphological changes and segregate into structurally different components, which we visualize by 2-photon fluorescence microscopy and generalized polarization analysis using the fluorescent probe Laurdan. Our results highlight the crucial role of cholesterol for mediating interactions between physiologically relevant membranes and α-synuclein.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid; Laurdan fluorescence; Membrane phase separation; Membranes; Multiphoton microscopy; Oligomer; Parkinson’s disease; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 26297828     DOI: 10.1016/j.febslet.2015.08.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  The role of lipids in α-synuclein misfolding and neurotoxicity.

Authors:  Cathryn L Ugalde; Victoria A Lawson; David I Finkelstein; Andrew F Hill
Journal:  J Biol Chem       Date:  2019-05-07       Impact factor: 5.157

2.  Imaging of neuronal tissues by x-ray diffraction and x-ray fluorescence microscopy: evaluation of contrast and biomarkers for neurodegenerative diseases.

Authors:  Eleonora Carboni; Jan-David Nicolas; Mareike Töpperwien; Christine Stadelmann-Nessler; Paul Lingor; Tim Salditt
Journal:  Biomed Opt Express       Date:  2017-09-05       Impact factor: 3.732

Review 3.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 4.  Interplay between α-synuclein amyloid formation and membrane structure.

Authors:  Emma I O'Leary; Jennifer C Lee
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-10-02       Impact factor: 3.036

5.  Robust Sequence Determinants of α-Synuclein Toxicity in Yeast Implicate Membrane Binding.

Authors:  Robert W Newberry; Taylor Arhar; Jean Costello; George C Hartoularos; Alison M Maxwell; Zun Zar Chi Naing; Maureen Pittman; Nishith R Reddy; Daniel M C Schwarz; Douglas R Wassarman; Taia S Wu; Daniel Barrero; Christa Caggiano; Adam Catching; Taylor B Cavazos; Laurel S Estes; Bryan Faust; Elissa A Fink; Miriam A Goldman; Yessica K Gomez; M Grace Gordon; Laura M Gunsalus; Nick Hoppe; Maru Jaime-Garza; Matthew C Johnson; Matthew G Jones; Andrew F Kung; Kyle E Lopez; Jared Lumpe; Calla Martyn; Elizabeth E McCarthy; Lakshmi E Miller-Vedam; Erik J Navarro; Aji Palar; Jenna Pellegrino; Wren Saylor; Christina A Stephens; Jack Strickland; Hayarpi Torosyan; Stephanie A Wankowicz; Daniel R Wong; Garrett Wong; Sy Redding; Eric D Chow; William F DeGrado; Martin Kampmann
Journal:  ACS Chem Biol       Date:  2020-08-12       Impact factor: 5.100

6.  A Triple Role for a Bilayer: Using Nanoliposomes to Cross and Protect Cellular Membranes.

Authors:  Daniel E Otzen; Dina Morshedi; Hossein Mohammad-Beigi; Farhang Aliakbari
Journal:  J Membr Biol       Date:  2021-01-11       Impact factor: 1.843

7.  Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.

Authors:  Colleen S Limegrover; Raymond Yurko; Nicholas J Izzo; Kelsie M LaBarbera; Courtney Rehak; Gary Look; Gilbert Rishton; Hank Safferstein; Susan M Catalano
Journal:  J Neurosci Res       Date:  2021-01-22       Impact factor: 4.164

8.  DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

Authors:  N Plotegher; G Berti; E Ferrari; I Tessari; M Zanetti; L Lunelli; E Greggio; M Bisaglia; M Veronesi; S Girotto; M Dalla Serra; C Perego; L Casella; L Bubacco
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

Review 9.  Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Authors:  Fatemeh Nouri Emamzadeh
Journal:  J Mol Neurosci       Date:  2017-07-10       Impact factor: 3.444

Review 10.  The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders.

Authors:  Michał Kosowski; Joanna Smolarczyk-Kosowska; Marcin Hachuła; Mateusz Maligłówka; Marcin Basiak; Grzegorz Machnik; Robert Pudlo; Bogusław Okopień
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.